Health Secretary Robert F. Kennedy Jr. has announced that he will allow the widespread use of unapproved peptide injections despite the Food and Drug Administration previously advising people not to use them.

Under Kennedy’s new policy, the Health and Human Services Department will not take enforcement action against doctors, pharmacies and other facilities that sell six peptide compounds.

Compounding is a process in which a medically supervised person combines or alters ingredients of a drug to create a medication tailored to that person’s needs. There are already some FDA-approved peptide compounds, including insulin for diabetes and GLP-1 drugs for weight loss.

Compounded drugs are not FDA-approved, and while HHS admitted in a document shared on their website Wednesday that these drugs can “pose risks to patients,” the department believes “there is significant interest in the use of these peptides in compounding.”

HHS argued that easing access to peptides will discourage people from using…